Cervomed to present at the 2023 roth healthcare opportunities conference

Boston , oct. 5, 2023 /prnewswire/ -- cervomed inc. (nasdaq: crvo), a clinical-stage company focused on developing treatments for degenerative diseases of the brain, today announced it will participate in the 2023 roth healthcare opportunities conference on thursday, october 12, 2023 in new york. members of the company's senior management team will be presenting and hosting 1x1 meetings at the conference.
CRVO Ratings Summary
CRVO Quant Ranking